BlackRock, Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-05 12:21 pm Sale | 2024-03-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 6,825,399 4.500% | -514,055 (-7.00%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 7,339,454 5.700% | 1,090,368 (+17.45%) | Filing |
| 2023-04-06 09:29 am Sale | 2023-03-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 6,249,086 5.000% | -209,888 (-3.25%) | Filing |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 6,458,974 5.200% | 584,616 (+9.95%) | Filing |
| 2022-08-09 4:02 pm Purchase | 2022-07-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 5,874,358 4.700% | 11,667 (+0.20%) | Filing |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 5,862,691 6.400% | -411,145 (-6.55%) | Filing |
| 2021-02-01 08:30 am Purchase | 2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 6,273,836 6.900% | 2,270,483 (+56.71%) | Filing |